Search PubMed⌕ Search

Biomedical subjects

G Ferretti

Publications and source records attributed to G Ferretti.

312 records · Page 18Linked to original sources
PubMedDate not supplied

Renovascular hypertension: a non-invasive Duplex scanning screening.

A Duplex-Scanner was used to screen 62 patients with severe hypertension, queried renovascular. Ten results were technically unsatisfactory and in the remaining 52 highlighted flow alterations in the renal arteries of 29 patients were found. Control angiographies confirmed renal artery stenosis in 27 cases. Comparative statistical analyses proved the test to be both highly sensitive and specific, considering other screening methods currently used in diagnosing renovascular hypertension--which include endovenous digital subtraction angiography. Results confirmed the Duplex-Scanner as a reliable renovascular hypertension screener as well as being a non-invasive method with no potentially toxic effects.

Adult↗
PubMedDate not supplied

Hunter's syndrome and oral manifestations: a review.

Review of the literature on Hunter's syndrome and oral manifestations in pediatric dental patients including the primary and secondary systemic manifestations are presented. Numerous oral manifestations are presented as well. Based on the cases presented in the reviewed studies, little information is available on oral considerations and treatment of these children. Early restoration of the oral cavity is important prior to treatment of the disease itself.

Bone Marrow Transplantation↗
PubMedDate not supplied

A comparative study of midazolam to meperidine/promethazine as an IM sedative technique for the pediatric dental patient.

This study evaluated the efficacy and safety of midazolam (0.2 mg/kg) as an IM sedative agent in the pediatric population as compared to the standard IM meperidine (2.0 mg/kg)/promethazine (1.0 mg/kg) sedation technique. Ten pediatric dental patients, ASA Class I, were evaluated in this double-blind, randomized, crossover study. The patients ranged in age from two to four years. Vital signs, sedation levels, and anxiety levels were evaluated. Midazolam was shown to be safe, but the inferior drug compared to the standard IM meperidine/promethazine sedation technique.

Analgesics, Opioid↗